130 related articles for article (PubMed ID: 28985021)
21. Polymorphisms in the interleukin-4 receptor gene are associated with better survival in patients with glioblastoma.
Scheurer ME; Amirian E; Cao Y; Gilbert MR; Aldape KD; Kornguth DG; El-Zein R; Bondy ML
Clin Cancer Res; 2008 Oct; 14(20):6640-6. PubMed ID: 18927306
[TBL] [Abstract][Full Text] [Related]
22. HIF-1α genetic variants and protein expression confer the susceptibility and prognosis of gliomas.
Yi L; Hou X; Zhou J; Xu L; Ouyang Q; Liang H; Zheng Z; Chen H; Xu M
Neuromolecular Med; 2014 Sep; 16(3):578-86. PubMed ID: 24929654
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-211 expression is down-regulated and associated with poor prognosis in human glioma.
Zhang J; Lv J; Zhang F; Che H; Liao Q; Huang W; Li S; Li Y
J Neurooncol; 2017 Jul; 133(3):553-559. PubMed ID: 28551850
[TBL] [Abstract][Full Text] [Related]
24. Targeted detection of genetic alterations reveal the prognostic impact of H3K27M and MAPK pathway aberrations in paediatric thalamic glioma.
Ryall S; Krishnatry R; Arnoldo A; Buczkowicz P; Mistry M; Siddaway R; Ling C; Pajovic S; Yu M; Rubin JB; Hukin J; Steinbok P; Bartels U; Bouffet E; Tabori U; Hawkins C
Acta Neuropathol Commun; 2016 Aug; 4(1):93. PubMed ID: 27577993
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Adjuvant Radiation Therapy Alone and Chemotherapy Alone in Surgically Resected Low-Grade Gliomas: Survival Analyses of 2253 Cases from the National Cancer Data Base.
Wu J; Neale N; Huang Y; Bai HX; Li X; Zhang Z; Karakousis G; Huang R; Zhang PJ; Tang L; Xiao B; Yang L
World Neurosurg; 2018 Apr; 112():e812-e822. PubMed ID: 29409888
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-15a down-regulation is associated with adverse prognosis in human glioma.
Xie T; Liu P; Chen L; Chen Z; Luo Y; Chen X; Feng Y; Luo X
Clin Transl Oncol; 2015 Jul; 17(7):504-10. PubMed ID: 25575767
[TBL] [Abstract][Full Text] [Related]
27. Genetic risk profiles identify different molecular etiologies for glioma.
Simon M; Hosking FJ; Marie Y; Gousias K; Boisselier B; Carpentier C; Schramm J; Mokhtari K; Hoang-Xuan K; Idbaih A; Delattre JY; Lathrop M; Robertson LB; Houlston RS; Sanson M
Clin Cancer Res; 2010 Nov; 16(21):5252-9. PubMed ID: 20847058
[TBL] [Abstract][Full Text] [Related]
28. Volumetric Analysis of Extent of Resection, Survival, and Surgical Outcomes for Insular Gliomas.
Eseonu CI; ReFaey K; Garcia O; Raghuraman G; Quinones-Hinojosa A
World Neurosurg; 2017 Jul; 103():265-274. PubMed ID: 28408263
[TBL] [Abstract][Full Text] [Related]
29. Impact of tumor location and pathological discordance on survival of children with midline high-grade gliomas treated on Children's Cancer Group high-grade glioma study CCG-945.
Eisenstat DD; Pollack IF; Demers A; Sapp MV; Lambert P; Weisfeld-Adams JD; Burger PC; Gilles F; Davis RL; Packer R; Boyett JM; Finlay JL
J Neurooncol; 2015 Feb; 121(3):573-81. PubMed ID: 25431150
[TBL] [Abstract][Full Text] [Related]
30. Insular glioma resection: assessment of patient morbidity, survival, and tumor progression.
Sanai N; Polley MY; Berger MS
J Neurosurg; 2010 Jan; 112(1):1-9. PubMed ID: 19612970
[TBL] [Abstract][Full Text] [Related]
31. Polymorphism -433 C>T of the Osteopontin gene is associated with the susceptibility to develop gliomas and their prognosis in a Chinese cohort.
Shen Z; Chen B; Hou X; Chen P; Zhao G; Fan J
Cell Physiol Biochem; 2014; 34(4):1190-8. PubMed ID: 25277531
[TBL] [Abstract][Full Text] [Related]
32. Low-grade glioma surgery in eloquent areas: volumetric analysis of extent of resection and its impact on overall survival. A single-institution experience in 190 patients: clinical article.
Ius T; Isola M; Budai R; Pauletto G; Tomasino B; Fadiga L; Skrap M
J Neurosurg; 2012 Dec; 117(6):1039-52. PubMed ID: 23039150
[TBL] [Abstract][Full Text] [Related]
33. Association of Telomerase Reverse Transcriptase Promoter Mutations with the Prognosis of Glioma Patients: a Meta-Analysis.
Wang X; Li X; Xu F; Zhang Y; Liu H; Tao Y
Mol Neurobiol; 2016 May; 53(4):2726-32. PubMed ID: 26351078
[TBL] [Abstract][Full Text] [Related]
34. Predictive and prognostic value of TLR9 and NFKBIA gene expression as potential biomarkers for human glioma diagnosis.
Miyar A; Habibi I; Ebrahimi A; Mansourpour D; Mokarizadeh A; Rajabi A; Farshgar R; Eshaghzadeh M; Zamani-Ahmadmahmudi M; Nodushan SM
J Neurol Sci; 2016 Sep; 368():314-7. PubMed ID: 27538656
[TBL] [Abstract][Full Text] [Related]
35. Recurrence and malignant degeneration after resection of adult hemispheric low-grade gliomas.
Chaichana KL; McGirt MJ; Laterra J; Olivi A; Quiñones-Hinojosa A
J Neurosurg; 2010 Jan; 112(1):10-7. PubMed ID: 19361270
[TBL] [Abstract][Full Text] [Related]
36. The Impact of PPARD and PPARG Polymorphisms on Glioma Risk and Prognosis.
Ding X; Han X; Yuan H; Zhang Y; Gao Y
Sci Rep; 2020 Mar; 10(1):5140. PubMed ID: 32198386
[TBL] [Abstract][Full Text] [Related]
37. Associations between polymorphisms of the ACYP2 gene and Liver cancer risk: A case-control study and meta-analysis.
Zhao W; Liu X; Yu Z; Xiong Z; Wu J; Sun Y; Niu F; Liu J; Jin T
Mol Genet Genomic Med; 2019 Jul; 7(7):e00716. PubMed ID: 31124313
[TBL] [Abstract][Full Text] [Related]
38. Survival of Ventricular and Periventricular High-Grade Gliomas: A Surveillance, Epidemiology, and End Results Program-Based Study.
Yang W; Xu T; Garzon-Muvdi T; Jiang C; Huang J; Chaichana KL
World Neurosurg; 2018 Mar; 111():e323-e334. PubMed ID: 29258929
[TBL] [Abstract][Full Text] [Related]
39. IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas.
Leeper HE; Caron AA; Decker PA; Jenkins RB; Lachance DH; Giannini C
Oncotarget; 2015 Oct; 6(30):30295-305. PubMed ID: 26210286
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of Genetic Variants in MIR3142HG in Susceptibility to and Prognosis of Glioma.
Guo X; Zhang M; Li Q; Zhao J; Wang B; Wang J; Mao P; Song J
Am J Clin Oncol; 2020 Jan; 43(1):1-8. PubMed ID: 31513017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
